Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein, Bim
- PMID: 12646560
- DOI: 10.1074/jbc.M301010200
Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein, Bim
Abstract
Both the ERK and phosphatidylinositol 3'-kinase (PI3K) signaling pathways can protect cells from apoptosis following withdrawal of survival factors. We have previously shown that the ERK1/2 pathway acts independently of PI3K to block expression of the BH3-only protein, BimEL, and prevent serum withdrawal-induced cell death, although the precise mechanism by which ERK reduced BimEL levels was unclear. By comparing Bim mRNA and Bim protein, expression we now show that the rapid expression of BimEL following serum withdrawal cannot be accounted for simply by increases in mRNA following inhibition of PI3K. In cells maintained in serum BimEL is a phosphoprotein. We show that activation of the ERK1/2 pathway is both necessary and sufficient to promote BimEL phosphorylation and that this leads to a substantial increase in turnover of the BimEL protein. ERK1/2-dependent degradation of BimEL proceeds via the proteasome pathway because it is blocked by proteasome inhibitors and is defective at the restrictive temperature in cells with a temperature-sensitive mutation in the E1 component of the ubiquitin-conjugating system. Finally, co-transfection of BimEL and FLAG-ubiquitin causes the accumulation of polyubiquitinated forms of Bim, and this requires the ERK1/2 pathway. Our findings provide new insights into the regulation of Bim and the role of the ERK pathway in cell survival.
Similar articles
-
Activation of ERK1/2 by deltaRaf-1:ER* represses Bim expression independently of the JNK or PI3K pathways.Oncogene. 2003 Mar 6;22(9):1281-93. doi: 10.1038/sj.onc.1206261. Oncogene. 2003. PMID: 12618753
-
Phosphorylation of Bim-EL by Erk1/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function.Oncogene. 2003 Oct 2;22(43):6785-93. doi: 10.1038/sj.onc.1206792. Oncogene. 2003. PMID: 14555991
-
c-Cbl is not required for ERK1/2-dependent degradation of BimEL.Cell Signal. 2007 Dec;19(12):2605-11. doi: 10.1016/j.cellsig.2007.08.008. Epub 2007 Aug 23. Cell Signal. 2007. PMID: 17884340 Free PMC article.
-
Extracellular signal-regulated kinases 1/2 are serum-stimulated "Bim(EL) kinases" that bind to the BH3-only protein Bim(EL) causing its phosphorylation and turnover.J Biol Chem. 2004 Mar 5;279(10):8837-47. doi: 10.1074/jbc.M311578200. Epub 2003 Dec 17. J Biol Chem. 2004. PMID: 14681225
-
Transforming growth factor beta (TGFbeta)-induced apoptosis: the rise & fall of Bim.Cell Cycle. 2009 Jan 1;8(1):11-7. doi: 10.4161/cc.8.1.7291. Epub 2009 Jan 30. Cell Cycle. 2009. PMID: 19106608 Free PMC article. Review.
Cited by
-
That which does not kill me makes me stronger; combining ERK1/2 pathway inhibitors and BH3 mimetics to kill tumour cells and prevent acquired resistance.Br J Pharmacol. 2013 Aug;169(8):1708-22. doi: 10.1111/bph.12220. Br J Pharmacol. 2013. PMID: 23647573 Free PMC article. Review.
-
TORC1 suppression predicts responsiveness to RAF and MEK inhibition in BRAF-mutant melanoma.Sci Transl Med. 2013 Jul 31;5(196):196ra98. doi: 10.1126/scitranslmed.3005753. Sci Transl Med. 2013. PMID: 23903755 Free PMC article.
-
Role of NOXA and its ubiquitination in proteasome inhibitor-induced apoptosis in chronic lymphocytic leukemia cells.Haematologica. 2010 Sep;95(9):1510-8. doi: 10.3324/haematol.2010.022368. Epub 2010 Apr 7. Haematologica. 2010. PMID: 20378569 Free PMC article.
-
Induction of BIM is essential for apoptosis triggered by EGFR kinase inhibitors in mutant EGFR-dependent lung adenocarcinomas.PLoS Med. 2007 Oct 9;4(10):e294. doi: 10.1371/journal.pmed.0040294. PLoS Med. 2007. PMID: 17927446 Free PMC article.
-
Gefitinib-induced killing of NSCLC cell lines expressing mutant EGFR requires BIM and can be enhanced by BH3 mimetics.PLoS Med. 2007 Oct;4(10):1681-89; discussion 1690. doi: 10.1371/journal.pmed.0040316. PLoS Med. 2007. PMID: 17973573 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous